of the general population affected, and males are more frequently affected than females. Although it is well recognized that an ethnic variation in the incidence of amyloidosis in FMF does occur, it is notorious that early death from amyloid is commonly seen in the Middle Eastern population as a result of renal involvement [9] . In the last two years, we have described several renal entities which have been encountered in patients with FMF in addition to amyloid [10] [11] [12] . In this study, we describe our experience and observation concerning the spectrum of renal involvement in patients with FMF.
Methods
Fifteen patients with FMF were referred to the Nephrology Service at Jordan University Hospital, Amman, for evaluation and assessment of the degree of renal involvement. Table 1 shows the demographic and clinical data about such individuals, and Table 2 shows the different parameters of renal involvement and results of renal biopsies. Markers for systemic diseases were excluded in all patients, for example, ASO titer, rheumatoid factor, HBsAg, ANA, anti-DNA complements, cryoglobulins, and all were negative. Percutaneous kidney biopsies were performed on all, utilizing fluoroscopy guidance in 12, and ultrasonographic guidance in three patients. Light microscopic examination was performed on all specimens and immunofluorescent staining in 13. All specimens were stained with Congo red stain and examined by polarized microscopy searching for amyloid deposits, as indicated by the presence of apple green birifringence. Results of kidney biopsies were as follows ( Table 2) .
Amyloid deposits were detected in seven biopsies only, and the remaining eight negative biopsies showed mesangial proliferative glomerulonephritis (MsPGN) in six and rapidly progressive glomerulonephritis (RPGN) in two. Electron microscopic examination was done on two biopsies from patients with MsPGN and no amyloid fibrils were detected.
Results

Treatment and outcome
Supportive management, such as salt and water restriction, occasional use of diuretics and coichicine, was performed to slow the progression of renal functional impairment. Both groups with the IgA and 1gM deposits demonstrated some improvement in kidney function and in the degree of protein excretion. Patients with RPGN were treated with colchicine, pulse steroid therapy, plasma exchange and hemodialysis. One patient improved and he is now off dialysis. The second patient continued to require hemodialysis until he received a transplantation. In two patients with amyloidosis, kidney function deteriorated to the point of requiring hemodialysis support, while in the remaining five patients, kidney function stabilized. severity of the attacks diminished once colchicine was started. Two days prior to admission he developed fever and abdominal pains, large joint arthralgias together with scrotal pain, swelling and redness of the skin above the right ankle. There were no chest pains or any urinary symptoms. Family history of similar illness was present, both an older sister and a younger brother suffer from the same illness and are being treated with colchicine.
Upon admission, clinical examination revealed temperature of 38.5°C, pulse 110/minute and blood pressure of 110/75 mm Hg. The patient looked sick and mildly dehydrated. Both chest and cardiac examinations were normal. Abdominal tenderness and guarding were present, liver span was 10 cm, the spleen was not palpable and bowel sounds were absent. The scrotum was swollen, red, tender and both the right testicle and the epididymis were also swollen and tender (epididymo-orchitis). Both elbows, wrists and knees were swollen and tender with limitation ofjoint movement. The skin above the right malleolus was red, indurated and tender (erysipelas-like lesion On light microscopic examination of the kidney biopsy specimen, 16 glomeruli were seen. All showed diffuse mesangeal proliferative glomerulonephritis with occasional polymorphonuclear cells. There was no sclerosis or crescent formation (Fig.   1 ). Congo red stain was negative for amyloidosis. Immunofluorescent staining was strongly positive for IgA(+ + +) and C3(+) in a granular pattern in the mesangium (Fig. 2) .
Colchicine 0.6 mg orally was given every hour for a total of five doses, and resulted in marked improvement of the abdominal pains, scrotal swelling, skin lesion and joint swelling. After that he was maintained on colchicine 0.6 mg twice daily; when he was seen in the clinic two, four and six months later he was asymptomatic. Urinalysis showed 1 + protein, 1 to 2 red cells per high power field and 0.6 gram protein excretion per 24 hours. Serum creatinine was 0.8 mgldl and the serum albumin Comment. This case represents non-amyloid glomerular disease (IgA nephropathy) in a patient with FMF.
Discussion
Familial Mediterranean Fever (FMF) is an autosomal recessive disorder which affects mainly Sephardic Jews, Armenians and Arabs and it is characterized by recurrent episodes of polyserositis and fever [2] . The pathogenesis of this disorder is not known, but since its initial description in 1945 [13] , several authors have suggested hypersensitivity and genetic or autoimmune mechanisms [14, 15] . FMF is potentially a fatal illness 40% of patients were Arabs owing to the high incidence of renal amyloidosis that complicates this disorder [2, 16] . In fact, the development of amyloidosis has been recognized as an ominous prognostic feature of this disease.
The frequency of this complication varies among the different ethnic groups and countries (Table 3 ). In the Sephardic Jews of Israel, [2, 17, 18 ] the incidence of amyloidosis is higher (7.2% up to 26.5%) than that in the Ashkenazi Jews of the United States [19] , where it is close to zero. Similarly, among the Armenians the incidence of amyloidosis complicating FMF varies dramatically and depends upon where they reside and if amyloidosis was seriously considered in their diagnoses. In a series of 120 Armenian patients with FMF residing in Lebanon, Khachadurian and Armenian [20] reported an incidence of 7.5%, while in the one hundred Armenians residing in the United States reported by Schwabe and Peters [3] , no single case of amyloidosis was reported.
Among Arab patients with FMF, the frequency of amyloidosis is also quite variable, ranging from 0 to 25%. The reason for this latitude seems to depend on how completely such patients were tested and if amyloidosis was seriously considered when the diagnosis was decided. Reimann et al [21] had renal lesions other than amyloid. Patients in this last category clinically presented with transient or persistent hematuria and albuminuria, particularly during attacks, and a variety of glomerulonephritis, including acute post-streptococcal gbmerulonephritis and hypersensitivity angiitis. Histologically a good number of kidney biopsies showed mesangial proliferative glomerubonephritis, but no immunofluorescent studies were available. In 1982, Flatau, Kohn and Schiller [301 reported 10 episodes of Henoch-Schonlein purpura (HSP) in eight patients with FMF, and kidney biopsies were performed in two patients which showed focal mesangial proliferative glomerulonephritis with granular mesangial C3 deposits in one patient only, but there were no IgA, IgG and 1gM deposits. During the last two years, we were successful in describing a variety of non-amyloid renal lesions in patients with FMF. In 1988, we reported the presence of intense mesangial IgA deposits in a granular pattern in two patients with a long history of FMF [10] . Both patients were found to have proteinuria, microscopic hematuria and elevated serum IgA levels during the acute attacks. Treatment with cotchicine resulted in both subsidence of the acute attacks and a decrease in the degree of proteinuria. A third case has been added recently, and it is presented here in our series in detail, as an illustrative example.
In 1989, we reported the presence of rapid progressive glomerulonephritis (RPGN) type 2 without amyloidosis in two patients with FMF. Both patients presented with gross hematuna and oliguria, and they were found to be in renal failure; kidney biopsy showed RPGN in both [11] . In 1990 we also reported the presence of 1gM nephropathy in three patients with FMF in the absence of amyloidosis [12] . Again, these three patients were found to have both microscopic hematuria and proteinuria during the acute episodes of FMF. Excellent recovery and response to colchicine was obtained, both clinically and in the form of normalization of urinary function.
The presence of the immunoglobulin IgA and 1gM mesangial deposits in patients with FMF may represent an immunoreactant mechanism or simple entrapment of these substances as the result of the mesangial dysfunction in clearing and processing immunologically-irrelevant macro-molecular aggregates. The frequent association of mesangial C3 and as well as mesangial proliferation has been invoked in support of an immunopathological role in these cases. Similarly, recent evidence suggests that an immunological mechanism may play a major role in the pathogenesis of FMF [31] . The findings of immune complexes in 50% of patients with FMF [32] , complement consumption during attacks [33] , the increase in the level of urinary fibrogen degradation products and the return of these tests to normal at the end of acute attacks [31] , are good supportive evidence that an immunological process may underlie FMF. Thus, the finding of both mesangial 1gM and IgA deposits in patients with FMF may represent an immune reactant mechanism rather than chance alone. In addition, the occurrence of type 2 RPGN in patients with FMF is not surprising, because this represents immune complex-mediated disease. In view of the clear association and the clinical similarities between HSP and FMF [30] , the occurrence of IgA nephropathy in both FMF [10] and HSP [34] , and the fact that both IgA nephropathy and HSP are associated with type 2 RPGN [35] , it is not surprising that this disorder has been encountered among patients with FMF. In spite of the fact that we report eight cases of non-amyloid glomerular disease among 15 patients with FMF, there are no good epidemiological studies showing that non-amyloid glomerular disease is more frequent in patients with FMF than in the general population; however, amyloid renal disease is definitely more common in FMF patients than in the general population [16] .
Finally, some of our patients were taking colchicine intermittently when they developed the non-amyloid glomerular disease, but not amyloidosis. It is possible that the use of this drug, even intermittently, played a major role in preventing the development of amyloidosis in this group of patients, as has been suggested recently by Zemer et al [36] . Of equal importance is the improvement of renal findings in the same group of patients when colchicine was given in large doses to suppress the acute attack of FMF [37] , and then maintained on a regular basis afterwards. It is possible that such a high dose may also suppress the acute inflammatory changes affecting the kidneys. However, this is speculation and further studies are needed.
In conclusion, renal involvement in FMF includes both amyloid and non-amyloid glomerular diseases, and colchicine treatment is quite effective in both treating the acute attack and the prevention of amyloidosis in FMF.
